- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: December 2017
- Public Summary Document (PSD) December 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) December 2017 PBAC Meeting - Word
Everolimus – December 2017
Everolimus: Tablet, dispersible, 2 mg, Tablet, dispersible, 3 mg, Tablet, dispersible, 5 mg; Afinitor®
Last updated
26 October 2018